FairScope Lab
EN 繁中 简中

GILD

Valuation Healthcare · Drug Manufacturers - General Data as of 2025-12-31

P/E Ratio · Metrics

P/E Ratio

17.61

PEG Ratio

0.23

Dividend Yield

-

Gross Margin

86.84%

Net Margin

27.55%

Revenue CAGR 3Y

2.36%

ROE

38.61%

ROA

14.79%

Buyback Yield

0.08%

Current Ratio

1.68

Magic Earn Yield

-

Altman Z-Score

-

Fair Value River

Score

Valuation 78
Profitability 70
Growth 8
Health 56
Yield 1
← Back to Dashboard